Purines and pyrimidines in malarial parasites

Area of Science:

• Biochemistry
• Parasitology
• Medicinal Chemistry

Background:

• Plasmodium falciparum malaria parasites require distinct metabolic pathways absent in human erythrocytes for replication.
• These pathways include purine salvage, de novo pyrimidine biosynthesis, and the folate cycle.
• Parasites also modify host erythrocyte membranes to alter purine transport.

Purpose of the Study:

• To identify and characterize Plasmodium-specific metabolic enzymes as potential targets for antimalarial chemotherapy.
• To explore novel therapeutic strategies by exploiting differences between parasite and host metabolic processes.

Main Methods:

• Cloning of Plasmodium enzyme genes and comparison with human homologs.
• Purification and biochemical/kinetic characterization of Plasmodium enzymes.
• Investigating the potential of enzyme inhibitors and altered nucleoside transporters as therapeutic agents.

Main Results:

• Plasmodium enzymes show high homology to human counterparts but possess distinct physicochemical and kinetic properties.
• Inhibition of specific enzymes like dihydroorotate dehydrogenase (DHO-DHase) shows therapeutic promise.
• Targeting the IMP to AMP and IMP to GMP pathways presents a viable chemotherapeutic strategy.

Conclusions:

• Plasmodium enzymes with unique kinetic and physical properties are promising targets for antimalarial drug development.
• Targeting essential parasite metabolic pathways, such as DHO-DHase, offers a potential route for novel antimalarial therapies.
• Exploiting altered nucleoside transporters in infected cells allows for selective delivery of cytotoxic compounds, presenting a new approach to combat malaria.